Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
DPH research center updates: fentanyl drives opioid mortality; stimulant harms require broader prevention approach
Summary
Researchers at the Department of Public Health’s Center on Substance Use and Health briefed commissioners on ongoing clinical trials, the dominant role of fentanyl in opioid deaths, and a push to treat stimulant‑related harms more like chronic disease, while federal research funding uncertainty threatens program capacity.
Dr. Coffin, of the Center on Substance Use and Health within DPH’s Population Health Division, presented the center’s recent studies and findings and described how drug‑supply changes are altering overdose patterns. The center’s work spans clinical trials, epidemiology and academic detailing with local providers.
“Fentanyl… is responsible basically for 95 percent of our opioid deaths,” Dr. Coffin told the commission, summarizing the center’s analysis of opioid fatalities. He said fentanyl’s potency has reduced the ability of behavioral interventions to lower opioid…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
